Enhance your practice with CME and tools that focus on the management of neurological conditions.
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Kaitlin Batley, MD
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Ethan Meltzer, MD
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
The New Era of Targeted Therapy for Myasthenia Gravis
Shruti Raja, MD, MHS
Precision Medicine for Myasthenia Gravis
Discharge Planning After Myasthenic Crisis
Qihua Fan, MD
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
Dani Cabral, MD
David Weisman, MD
Recurrence as the Rule: BD Symptoms Persist and Cycle
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
Exploring the Potential Role of Emerging Muscarinic Therapies in the Treatment of Bipolar Disorder
Uncovering TK2d: How to Navigate Diagnostic Challenges
Navigating Emerging Biomarkers in MS Care
The Role of B-Cell Depletion in MS Care
David Hafler, MD, FANA, MSc
Exploring Genetic Links Between EBV Clearance and MS Risk
Recognizing the Signs of TK2 Deficiency
Immunologic Phenotyping: The Future of Personalized MG Care
New Therapies, New Strategy: Rethinking MG Inpatient Care
Outcome Measures Capture Progression in Late-Onset TK2d
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.